Illumina advances its sequencing strategy with strong NovaSeq X momentum and clinical demand, but China's weakness and macro pressures cloud the outlook.

Liquid handling solutions support NGS workflows by enhancing throughput, minimizing manual error and standardizing library ...

Sir Shankar Balasubramanian and Sir David Klenerman -- the chemists whose DNA sequencing work took a once $1 billion genome down to a few hundred dollars -- weigh in on what it takes to bring real ...

Most genetic studies focus on people from European ancestry. But Africa has the richest diversity and must be included in ...

Chinese President Xi Jinping told U.S. CEOs traveling with President Trump to China that it will open further to American ...

Tesla CEO Elon Musk, Secretary of State Marco Rubio, Secretary of Defense Pete Hegseth, U.S. Trade Representative Jamieson Greer and Nvidia CEO Jensen Huang follow President Donald Trump as he steps ...

US President Donald Trump’s China visit has brought together some of America’s biggest CEOs, including Elon Musk, Tim Cook ...

Earnings call Devyser Diagnostics delivered strong Q1 2026 results with 24% revenue growth in fixed currencies and a gross margin of 81.6%. EBIT turned positive for the fourth consecutive quarter, ...

Dr Sahil Tulsi's groundbreaking PhD research from the University of KwaZulu-Natal challenges the traditional 'one-size-fits-all' approach to tuberculosis treatment, revealing how personalised medicine ...

Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early ...

This research involving human participants complies with all relevant ethical regulations, including obtaining informed consent from all participants through the recruitment sites. Ethical review and ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech company at ...